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A B S T R A C T
Ethnopharmacology relevance: He-Ying-Qing-Re Formula (HF) was empirically modiﬁed from Si-Miao-Yong-An
Decoction (SD), which was recorded in the literature of Divine Doctor's Secret Transmission, and has been
utilized for centuries to treat vasculopathy through clearing heat and accelerating bloodstream. HF has been
used as an eﬀective holistic treatment of diabetic retinopathy (DR) for decades and experimentally reported to
ameliorate retinal condition in diabetic mice.
Aim of the study: Our study aims to investigate the eﬀect of HF in preventing sustained hyperglycemia and
hyperlipidemia-associated retinal ganglion cell (RGC) cell death and its possible mechanism.
Materials and methods: Chromatographic ﬁngerprint of HF was obtained upon the UPLC-based analytic system;
Diabetic retinopathy was established in streptozotocin (STZ) injection-induced hyperglycemic mice; Alterations
of retinal structure was assayed by H&E staining. Expression of PSD-95 and CHOP in retinae was assessed by
immunoﬂuorescence; RGC cell line (mRGC) was used for in vitro study. Cell death was analyzed by ﬂow cy-
tometry; Intracellular reactive oxygen species (ROS) was measured by 2′,7′-dichloroﬂuorescin diacetate
(DCFDA); Apoptosis-related proteins and signaling were monitored with immunoblotting and colorimetric assay.
Results: Chlorogenic acid, ferulic acid, and rutin were identiﬁed in HF. HF attenuates the loss of RGCs, thinning
of inner retinal layers in diabetic mice. Furthermore, expressions of Brn3a and PSD-95 were restored while CHOP
level was downregulated upon HF treatment. In vitro study, HF alleviates H2O2-induced apoptosis of mRGCs and
loss of postsynaptic protein via scavenging ROS and suppressing ATF4/CHOP-mediated endoplasmic reticulum
stress and mitochondria-related pro-apoptotic factors, probably as cleaved-caspase-3, and phospho-p38 mitogen-
activated protein kinase (MARK). Meanwhile, both pro-survival protein levels like Bcl-2/Bcl-xL and postsynaptic
protein of PSD-95 were upregulated upon HF treatment.
Conclusion: HF administration was a valid therapeutic approach for DR treatment, oriented at the blockade of
endoplasmic reticulum- and mitochondria-dependent oxidative stress-induced retinal neurodegeneration in-
cluding RGC apoptosis.
1. Introduction
Diabetic retinopathy (DR) is characterized by progressive neurolo-
gical deﬁcits associated with concomitant retinal microvascular de-
generation that contributes to the inevitable and permanent visual
dysfunction (Kim et al., 2016; Ng et al., 2016). In accordance with the
recent trend in epidemiological-clinical twin study of DR, the diabetic
population worldwide will be approximately increased to 500 million
by 2030 (Whiting et al., 2011). Accordingly, numerous ophthalmic
therapies aimed at alleviation of hyperglycemia-induced retinopathy
have been proposed, including laser photocoagulation, vitrectomy and
intravitreal injection of anti-VEGF agents (Lee et al., 2015; Singh et al.,
2014; Tremolada et al., 2012). However, the aforementioned curative
interventions, which possess remarkable eﬀects in arresting the
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deterioration of retinal detachment, neurodegeneration, and neo-
vascularization, are insuﬃcient to prevent visual impairment. This
majorly caused by the limitation of speciﬁc therapeutic targets and
unavoidable side-eﬀects, such as peripheral vision loss, worsening of
macular edema and reduction in night vision in parallel with the deﬁ-
ciency of contrast sensitivity. Therefore, alternative pharmacological
therapies for DR treatment that not aﬀecting the visual functions are
urgently demanded.
Growing evidence has demonstrated that prevailing diabetes-in-
duced complications have been alleviated with minimal side-eﬀects via
the treatment of herbal medicines (Watal et al., 2014). Meanwhile,
more than 200 kinds of traditional medicinal plants as well as their
bioactive compounds are documented to possess anti-diabetic property
as illustrated via substantial screening methods (Yang et al., 2013c).
He-Ying-Qing-Re Herbal Formula (HF) was empirically modiﬁed from
Si-Miao-Yong-An Decoction (SD), which has been utilized for centuries
to treat patients with vasculopathy through clearing heat and accel-
erating blood stream with ingredients of Lonicera japonica, Glycyrrhiza
uralensis, angelica sinensis and scrophularia, based on the traditional
Chinese medicine theory from the literature of “Shen-Yi-Mi-Zhuan”
(Divine Doctor's Secret Transmission) written by Hua Tuo (A.D.
141–203), a renowned Chinese herbalist as “Medical Sage” in the Han
Dynasty of China (Liu et al., 2017b; Yang et al., 2013a). In the con-
temporary era, SD has experimentally reported to relieve diabetes with
retinal hemorrhage, feet syndrome as well as atherosclerotic upon
downregulating such expressions as TNF-α, IL-6, IL-8 and lipid levels in
blood (Cui et al., 2009; Yang and Liu, 2008; Zhang et al., 2010) The
optimized formula of HF derived from SD was ﬁrst created and clini-
cally used by Dr. Jusheng Zhou, an experienced expert in traditional
Chinese medicine at Longhua hospital of Shanghai, and shown bene-
ﬁcial for improving visual function with no reported ineluctable side-
eﬀects for decades (Ye and Zhang, 2012), suggesting that HF tended to
possess certain anti-DR characteristics.
It has been postulated that apoptosis of retinal ganglion cell (RGC),
a pathological and predominant hallmark of neurodegeneration in DR,
is involved in the progressive but irreversible reduction of the thickness
of inner retinal layer and vision loss (Adamiec-Mroczek et al., 2015).
The cross-sections of endoplasmic reticulum stress and mitochondria-
dependent oxidative stress to the diabetes-induced retinal pathology are
responsible for the acceleration of RGC apoptosis (Jia et al., 2014;
Wang et al., 2016). Conventionally, the activation of oxidative- and/or
endoplasmic reticulum-stress in retinal neural cells, including RGC, can
be induced by hyperglycemia-generated hydrogen peroxide (H2O2), an
endogenous reactive oxygen species (ROS), which also instigates the
onset of degenerative cascade of microvasculature involving break-
down of blood-retinal barrier (BRB) (Fan et al., 2016; More et al.,
2017). The misfolded or unfolded protein response can be accumulated
in the lumen of endoplasmic reticulum owing to the interruption of the
protein folding triggered by numerous stimuli, including over-
expression of H2O2 (Zhang and Kaufman, 2004). For example, up-reg-
ulation of the activating transcription factor 4 (ATF4) transcription
could facilitate the stimulation of potential downstream substrates such
as transcriptional factor C/EBP homologous protein (CHOP) and post-
synaptic density protein 95 (PSD 95) (Hetz, 2012; Wang et al., 2016; Xu
et al., 2005). In addition, the phosphorylation of p38 mitogen-activated
protein kinase (p38 MAPK) as well as the inactivation of pro-survival
Bcl-2 family members, are all involved in the initiation of endoplasmic
reticulum- and/or oxidative-stress (Sano and Reed, 2013). Although
inhibiting the expression of aforementioned proteins may reduce RGC
apoptosis, consensus on the proverbial pharmacological targets for the
alleviation of apoptosis-associated DR progression have not been
cleared. Therefore, a promising therapeutic strategy, based on the at-
tenuation of H2O2-induced endoplasmic reticulum- and/or oxidative-
stress, is worthy to be considered in combating RGC apoptosis in DR
progression.
Our previous study has showed that HF elicited beneﬁcial eﬀects on
the inhibition of advanced glycation end products generation via up-
regulating the expression of tight junction proteins, Zo-1 and Claudin-1,
of which factors lead to the decrease of fundus lesions such as hemor-
rhages, exudation and edema (Wang et al., 2015; Zhang et al., 2012).
Nonetheless, the clear mechanism of HF in neuroprotection of DR-in-
duced vision loss remains elusive. To clarify these above-mentioned
considerations, the present study aimed to investigate the potential
protective eﬀects of HF on RGC apoptosis associated with micro-
vascular degeneration caused by H2O2-induced endoplasmic reticulum-
and mitochondria-dependent oxidative stress, using the transformed
mouse RGC cell line (mRGC). In parallel, STZ, a natural chemical toxic
to pancreatic β-cells, is adopted to establish insulin-deﬁcient diabetic
mice. We have taken advantage of multiple assessment approaches to
elucidate the postulated properties of HF against DR both in vitro and in
vivo.
2. Materials and methods
2.1. Preparation of HF extract
HF consists of eight herbs and the mixed proportion of respective
herb in HF is illustrated in Fig. 1A–B. All the mentioned herbal names
can be checked in accordance with the database of www.theplantlist.
org (Fig. 1C). Raw herbs were obtained from the pharmacy of School of
Chinese Medicine (SCM), the university of Hong Kong (HKU), authen-
ticated by the executive manager of pharmacy dispensary of HKU.
Voucher specimens with speciﬁc storage code were well-deposited at
SCM, HKU. 10 times of ddH2O (w/v) was added and boiled twice for
one hour each time. The raw drug liquid was concentrated with a ﬁnal
concentration of 2 g dried crude herb per ml. HF extract was ﬁltered
and stored in − 80 °C until used.
2.2. Chromatographic ﬁngerprint analysis
Ultra Performance Liquid Chromatography (UPLC) (Thermo Fisher
Scientiﬁc, USA) system was utilized for the identiﬁcation and separa-
tion of sample components in HF, corresponding to the relative absor-
bance and peak time of known standard compounds, including
chlorogenic acid, ferulic acid, caﬀeic acid, acteoside and rutin (TAUTO,
China), and aimed to capture as many peaks as possible (Fig. 2A). C18
column (100 mm × 2.1 mm id) (ACE, UK) was used as solid phase and
the column temperature was maintained at 30 °C. Meanwhile, the
mobile phase contains binary solvent mixture of acetonitrile and 0.05%
KH2PO4 (PH = 2.5). The chromatographic gradient elution procedure
is illustrated in Fig. 2B while the monitoring wavelength is 330 nm with
a ﬂow rate of 0.5 ml min−1.
2.3. Animals interventions and Streptozotocin-induced DR model
Experimental procedures in this study were performed according to
the approved protocol of Committee on the Use Research (CULATR)
(Certiﬁcate Number: 3354-14) and ethical guidelines of Laboratory
Animal Unit aﬃliated to The University of Hong Kong (LAU, HKU) for
the use of laboratory animals. Male mice (C57BL/6N) ranging from 6 to
8 weeks of were purchased from LAU and housed in animal units in
LAU as well, which were placed under a 12 h light/dark schedule and
given free access to the food and water. Diabetic mice were established
via 5 consecutive intraperitoneal injections of streptozotocin (STZ;
55 mg/kg), which dissolved in citrate buﬀer (pH 4.5) (Sigma USA).
After 3 days of operation, mice with blood glucose lower than
15 mmol/l measured by a glucometer (Contour TS, Bayer, Germany)
were eliminated from this study. STZ-induced hyperglycemic mice were
randomly separated into four groups. Initially, insulin-treated
(Humulin, USA; 1 U/kg; n = 5) and untreated diabetic mice (n = 5) are
regarded as positive control and model group respectively. On the other
hand, the remaining mice with hyperglycemia received HF via daily
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gavage with two doses, 50 mg/kg (low dose; n = 5) and 100 mg/kg
(high dose; n = 5) respectively. Untreated non-diabetic mice were
utilized as normal control and daily given ddH2O as a model group.
Mice were sacriﬁced with overdose of pentobarbital (200 mg/kg) in-
jection once DR established.
2.4. Assessment of fasting, random blood glucose, intraperitoneal glucose
tolerance test and weight
To verify the hypoglycemic eﬃcacy of HF in DR treatment, fasting
blood glucose (FBG), random blood glucose (RBG) and intraperitoneal
glucose tolerance test (IPGTT) were measured with the same gluc-
ometer (Bayer, Germany). We performed weight once a week and FBG
measurements every 4 weeks respectively, while RBG was monitored at
3 days followed by 2 or 4 weeks after the last STZ injection. For IPGTT
measurement, mice were assigned to go through a persistent 12-h
fasting program followed by FBG measurement as baseline initially
followed by the assessment at 0.5, 1, 1.5, 2 h after blood glucose (2 g/
kg) injection. The area under the curve (AUC) evaluated the glucose
tolerance ability of mice, which was plotted by linking 5-time points in
each group.
2.5. Quantitative assessment of RGC loss and inner retinal layer thickness
Paraﬃn-embedded section technology combined with H&E staining
was utilized to observe the pathological changes of RGC loss and retinal
structure degeneration in DR mice. Brieﬂy, mice were euthanized with
overdose-injection of pentobarbital (200 mg/kg) and eyes were en-
ucleated immediately followed by ﬁxation with 4% PFA for 24 h. Then,
eyeballs were immersed in 70%, 80%, 90%, 95% ethanol once an hour
for gradient dehydration. Subsequently, eyecups were taken seriously
and immersed in 95% ethanol for 30 min followed by incubation with
100% ethanol for 10 min each. Afterwards, eyes were embedded with
paraﬃn and slid into sections (5 μm thick) along the vertical meridian
followed by deparaﬃnization and rehydration with xylene and graded
ethanol series (70%, 90%, and 100%) including H&E staining respec-
tively. Images were captured with a digital microscope (EVOS, USA) at
400× magniﬁcation. Quantiﬁcations of the number of RGCs and the
Fig. 1. Information of components in He-
Ying-Qing-Re Formula (HF). (A)
Representative ﬁgures of herbs in HF. (B)
Ratio of each herb in HF. (C) List of accepted
Botanical, Herbal and Chinese name of the
corresponding herb in HF with its voucher
number according to www.theplantlist.org.
Fig. 2. Chromatographic ﬁngerprinting
of HF and standards, using a gradient
elution procedure. (A)Chromatograms of
HF and standards with labeled peak time
respectively. I: chlorogenic acid; II: Ferulic
acid; III: Rutin (B) Detailed procedure of
UPLC gradient elution program.
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thickness of the ganglion cell-, inner nuclear- or inner plexiform layer
were performed in eight randomly selected vision ﬁelds with an iden-
tical area of 0.076 mm2 (275 × 275 µm), captured with a reference
micrometer in a microscope (Olympus BX43, Australia) under the same
conditions. The measurement of inner retinal layers was quantiﬁed with
Image J processing program (National Institute of Health, USA).
2.6. Immunoﬂuorescence analysis
The approaches for the preparation of paraﬃn-embedded retinal
slice were consistent with the methods described above. Deparaﬃnized
and rehydrated sections were heated in a 10 mM citrate buﬀer (pH 6.0)
for 1–2 min in a microwave oven for the procedure of antigen retrieval.
Subsequently, sections were rinsed with deionized water followed by
incubation with 1% H2O2 dissolved in PBS for 5 min. Then, samples
were immersed in blocking buﬀer, containing 10% bovine serum al-
bumin and 0.3%Triton X-100 in PBS, for 2 h and incubated with re-
spective anti-PSD 95 or anti-Brn3a primary antibody (1:300 dilution;
Abcam, UK) overnight at 4 °C. Thereafter, sections were inﬁltrated with
appropriate secondary antibody conjugated with Alexa-Fluor-488 or
-568 (1:500 dilution; Invitrogen, USA) and counterstained with DAPI.
Images were visualized and captured randomly with a confocal laser
microscope at 200× magniﬁcation (Carl Zeiss LSM 780, USA).
2.7. Cell culture and assessment of cell viability
mRGC cell, a cell line derived from mouse retinal ganglion cells, was
obtained from Ying-Run Biotechnology Inc. (Changsha, China) and
routinely maintained in DMEM supplemented with high glucose (4.5 g/
L), 10% fetal bovine serum, 100 U/ml penicillin and 100 g/ml strep-
tomycin (Gibco, USA). Cells were cultured at 37 °C in a humidiﬁed
incubator containing 5% CO2 and 95% air and passaged until cells
reach their conﬂuence of 80%.
mRGC cell viability was analyzed via MTT assay after diﬀerent in-
terventions (Sigma, USA). Brieﬂy, cells were seeded in 96-well plates at
cell density of 1.0 × 104 per well followed by 24 h of attachment. Then,
cells were cultured with diﬀerent concentrations of HF or H2O2 si-
multaneously or alternatively for 24 or 48 h respectively. Thiazolyl Blue
Tetrazolium Bromide (MTT, 5 mg/ml) in PBS was added to each well
and incubated for another 4 h at 37 °C. Afterwards, supernatants were
discarded and 100 μl DMSO was added to dissolve the crystal violet.
Eventually, plate was gently vortexed for 5 s and measured at 575 nm
using the BIO-RAD 680 microplate reader (Thermo Fisher Scientiﬁc,
USA). Experiments were performed in ﬁve replicates.
2.8. Flow cytometry analysis of cell apoptosis
To identify and evaluate the number of apoptotic mRGCs after dif-
ferent interventions, cells were collected and resuspended in 1x Binding
Buﬀer after washed twice with sterile PBS. Cells were ﬂuorescently
stained with 5 μl of PE Annexin V and 5 μl 7-AAD followed by in-
cubation for 15 mins in the dark according to the instructions of PE
Annexin V Apoptosis Detection Kit (BD Biosciences). The number of
viable or apoptotic cells were analyzed by Flow Cytometer (BD, USA).
2.9. Measurement of Caspase-3 activity
Caspase-3 activity was measured with a Caspase 3 Colorimetric
Assay Kit (Bio Vision, USA) following the manufacturer's instructions.
Protein extraction of mRGCs was harvested followed by proteolytic
reaction. Cleavage of the DEVD-pNA ﬂuorophore was read in the BIO-
RAD 680 microplate reader at the wavelength of 405 nm. Caspase 3
activity was determined by comparing the results with the relative
absorption of the untreated control.
2.10. Measurement of cellular ROS production
ROS levels were detected in mRGCs with the probe DCFDA ac-
cording to the procedures from the manufacturer (Abcam, USA).
Brieﬂy, cells were seeded on a dark, opaque‐bottomed 96‐well plate at
the density of 2.5*105. After 24 h attachment, the supernatant was
discarded and cultured for 45 min in 1× Buﬀer with 100 μM DCFDA
per well at 37 °C. Afterwards, DCFDA solution was removed followed
by the addition of 1 × PBS. The ﬂuorescence yield level, which is
identical to the intracellular ROS content, was analyzed using a ﬂuor-
escence plate reader at Ex/Em = 485/535 nm (BMG LABTECH,
Germany) and expressed as the percentage of untreated control.
2.11. Western Blot analysis
Ice-cold radioimmunoprecipitation assay (RIPA) buﬀer was utilized
to lyse samples for 30 min at 4 °C followed by centrifugation in a mi-
crocentrifuge at 12,000 rpm at 4 °C for 20 min 50 μg of cellular protein
mixed with loading dye was separated by electrophoresis on 10% or
12% SDS-PAGE and electroblotted onto polyvinylidene ﬂuoride mem-
brane (PVDF, Bio-Rad). PVDF membrane was then transferred to
blocking buﬀer containing 5% bovine serum albumin for 2 h followed
by incubation with relevant primary antibodies, anti-Phosphor-p38
MARK, -CHOP, -Bcl-2, -Bcl-xL, -GAPDH (CST, USA), -ATF4 and -PSD-95
(Abcam, UK), with gentle shaking overnight. Afterwards, the membrane
was incubated with secondary antibody for 2 h at room temperature.
Immunoreactive bands were visualized by ECL select kit (GE
Healthcare, Germany) while band intensities images were captured and
quantiﬁed by a chemiluminescence imaging system (Bio-Rad ChemiDoc
XRS+, USA).
2.12. Statistical analysis
All data were analyzed using SPSS software (version 18.0; SPSS Inc.,
USA) and presented as the means± standard deviation (SD)
throughout the test. Unpaired Student t-test or Mann-Whitney test was
utilized to the comparison between two groups, while one-way analysis
of variance (ANOVA) with Bonferroni post-test or Kruskal-Wallis test
was performed to assess the comparison of more than two groups. A
value of P<0.05 was regarded as a signiﬁcant diﬀerence.
3. Results
3.1. Chromatographic ﬁngerprinting analysis of HF
Qualitative assessment of ingredients in HF extract was tentatively
characterized by UPLC system and its chromatographic ﬁngerprint was
established as illustrated in Fig. 2B. Approximately 12 chromatographic
peaks were identiﬁed as the characteristic proﬁle in HF. Among them,
three isolated compounds were identiﬁed in comparison with the
UV–visible absorption spectra and retention time of the selected stan-
dards, including chlorogenic acid, ferulic acid and rutin.
3.2. HF might not impede weight loss and exhibit a remarkable
hypoglycemic eﬀect on STZ-induced diabetic mice
Metabolic dysfunction, caused by increased-glucose level, resulted
in weight loss for patients with type 1 diabetes and contributing to the
deterioration of DR. Hypoglycemic is deemed as a predominant ther-
apeutic strategy for DR treatment. However, our present data showed
that HF could not induce a striking hypoglycemic eﬀect on DR mice,
which is consistent with our previous ﬁndings (Wang et al., 2015). As
shown in Fig. 3A-E, neither low nor high dose administration of HF
leads to RBG reduction (Fig. 3C, P all> 0.05 vs. model). Insulin, a
common anti-diabetic agent could signiﬁcantly prevent hyperglycemia,
as observed from the results of RBG, FBG, IPGTT, AUC (Fig. 3B-E, P
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all< 0.001 vs. model), without inducing regression of weight loss in
STZ-induced diabetic mice (Fig. 3A, P>0.05 vs. model). Whereas, HF
was not as eﬀective as insulin was in hypoglycemic action. Low-dose HF
treatment elicited beneﬁcial function on lowering FBG (P<0.05 vs.
model), but a weak eﬀect on the amelioration of glucose tolerance, RBG
and weight loss (P all> 0.05 vs. model). High-dose HF administration
improved the sensitivity of glucose tolerance (P<0.05 vs. model), but
associated with ineﬀective control of weight loss (P>0.05 vs. model).
Our ﬁndings validated that HF might be incapable of inducing hy-
poglycemic activity as well as preventing weight loss for DR treatment.
3.3. High-dose of HF inhibited the reduction of inner retinal layer thickness
and loss of RGC in STZ-induced diabetic mice
The majority of correlative research studies reported that patients
and mammals undergoing DR lead to the degeneration of neuronal
structure in retinae such as the decrease of the thickness of ganglion cell
layer (GCL), inner nuclear layer (INL), inner plexiform layer (IPL) and
progressive loss of RGCs (Choi et al., 2017; van Dijk et al., 2010). We
quantiﬁed the number of RGCs and measured the thickness of GCL, INL,
and IPL in H&E stained retinal sections (Fig. 3G–J). The considerable
loss of RGCs in GCL is observationally detected in untreated diabetic
mice, which could be reversed via insulin and high-dose HF treatments
(P all< 0.05 vs. model). Furthermore, quantitative measurement illu-
strated a trend of thickness reduction of GCL, INL, IPL in model mice,
with signiﬁcant alterations emerged in the insulin and high-dose HF
treated groups, as compared to that of model group (P all< 0.05). In
addition, the protective actions against the reduction of GCL, INL, IPL
thickness as well as the loss of RGCs were not remarkable upon low-
dose HF treatment, compared with untreated diabetic mice (P>0.05).
In regard to these outcomes, HF might be deemed as a promising
treatment option to reduce the thinning of the thickness of GCL, INL,
IPL associated with attenuation of RGC loss in the progression of DR.
Fig. 3. HF administration might not signiﬁcantly block STZ-induced hyperglycemia and weight loss but protect loss of RGCs and retinal structure degeneration in diabetic
mice. (A) Changes of body weight. (B) Detection of fasting blood glucose. (C) Quantiﬁcation of random blood glucose from D3 onwards after diﬀerent interventions. (D, E) Intraperitoneal
glucose tolerance test and its related areas under the curve (AUC) in diabetic mice with 8-week treatment, respectively. (F) H&E staining of retinal histologic sections. GCL: ganglion cell
layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (G) Quantiﬁcation of H&E stained RGC cells. (H-J) Measurement of
thickness of GCL, INL, and IPL with H&E staining respectively. All data are presented as mean± S.D. HF (LD): HF 50 mg/kg; HF (HD): HF 100 mg/kg. (*) P<0.05 (**) P<0.01 and
(***) P<0.001 versus Model. (###) P<0.001 versus Control. (&) P<0.05 and (&&&) P<0.001 Control versus Model. Scale bar, 50 µm for all images.
C. Zhang et al. Journal of Ethnopharmacology 214 (2018) 179–189
183
3.4. HF restored expression of Brn3a and PSD 95 proteins accompanied
with the enhancement of CHOP protein expression in retinae of diabetic mice
To further shed light on the underlying mechanisms of HF for the
reduction of RGC loss, a confocal laser is utilized to visualize PSD 95-,
Brn3a- and CHOP-positive RGCs. Sustained diminishing in the expres-
sion of PSD 95 protein and RGC-speciﬁc marker Brn3a associated with
the accelerated expression of CHOP illustrated the pathological stage of
RGCs undergoing neurodegenerative alternations in parallel with cell
apoptosis (Nadal-Nicolas et al., 2009; Wang et al., 2016). Dramatically
declined expressions of PSD 95-, Brn3a- and DAPI- positive signals in
GCL of untreated diabetic mice (Fig. 4B) compared with untreated
nondiabetic mice (Fig. 4A). This may account for the striking loss of
RGCs and postsynaptic dendrites reﬂected by the sparse DAPI-stained
cell nuclei of RGCs. Compared with untreated diabetic mice, no obvious
decrease in the number of PSD 95- or Brn3a-labeled RGCs was observed
in HF-treated diabetic mice (Fig. 4D–E), which are similar to those with
insulin treatment (Fig. 4C). Furthermore, CHOP, a speciﬁc protein on
behalf of the activation of endoplasmic reticulum- or ROS-stress
mediated apoptosis, was expressed at low levels with Brn3a under the
physiological condition in high-dose HF treatment group (Fig. 4F, J),
while CHOP/Brn3a-colocalized RGCs were massively detected in un-
treated DR mice (Fig. 4G). In contrast, faintly RGCs stained with CHOP
and Brn3a coupled with the loss of DAPI-stained RGCs were detectable
in insulin or low-dose HF treated DR mice. Thus, we further conﬁrmed
that HF administration protected the decreased number of RGCs from
apoptosis and the absence of postsynaptic proteins via the restoration of
Brn3a and PSD 95 protein expression and downregulation of CHOP
levels in retinae of STZ-induced diabetic mice.
3.5. HF attenuated H2O2-induced mRGC cell death
To evaluate the inhibitory action of HF on the alleviation of H2O2-
induced mRGC death, quantiﬁcation of viable mRGC cells after corre-
sponding interventions was assessed by MTT assay. The survival rate of
mRGCs cultured with H2O2 was decreased in a dose-dependent manner
(Fig. 5A). It is demonstrated that the half maximum inhibitory con-
centration (IC50) of H2O2-treated mRGC for 24 h is about 0.236 mM,
equivalent to its log10-IC50 value is− 0.628. Thus, incubation of H2O2
with the optimal concentration of 0.236 mM for 24 h was adopted for
subsequent in vitro experiment to evaluate the anti-apoptotic eﬀect of
HF on H2O2-induced mRGC damage. Next, the cytotoxicity of HF alone
on mRGC cell viability was examined by exposing mRGCs to numerous
concentrations (0–800 μg/ml) of HF for 24 h. HF stimulation up to
400 μg/ml did not elicit a potent cytotoxic eﬀect, whereas statistically
signiﬁcant negative response was detected at 600 and 800 μg/ml, as
compared to control group (Fig. 5B).
Furthermore, we explored whether HF protects H2O2-induced RGC
cell death in DR by co-administering 0.236 mM H2O2 and increasing
dose of HF (13–400 μg/ml) to mRGCs simultaneously or alternately.
Initially, mRGC co-treated with HF and H2O2 at the same time elicited
an inhibitory action on mRGC death, but the neuroprotection of ac-
celerating RGC survival is relatively minor (Fig. 5C), compared to the
profound inhibitory eﬀect measured by HF pretreatment for 24 h
(Fig. 5D). It was noteworthy that pretreatment with the dose higher
than 100 μg/ml of HF for 24 h did not exhibit improvement on H2O2-
Fig. 4. HF administration attenuates the decrease in the number of Brn3a- and PSD 95- positive signaling associated with promoting the reduction of CHOP-positive RGCs in
diabetic mice. (A-J) Representative confocal microphotographs of retinal tissues from untreated or STZ-induced diabetic mice after diﬀerent interventions as described above. Retinal
slices were immunostained with Alexa Fluor 488 (green) or Alexa Fluor 568 (red) to visualize the conjoined expression of Brn3a (green) and PSD 95/CHOP (red) in each group
respectively. RGCs were speciﬁcally labeled with Brn3a that located in the GCL of retinae. Merged images show the colocalization of Brn3a and PSD 95/CHOP (red) accompanied with
DAPI-stained cell nuclei (blue) in retinae. HF (LD): HF 50 mg/kg; HF (HD): HF 100 mg/kg. Scale bar, 50 µm for all images. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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induced mRGC death in comparison with the lower dose. Therefore, the
optimal inhibitory eﬀect on the alleviation of H2O2-induced cell death
is pretreatment with HF at an approximate dose of 50 μg/ml. Taken
together our results demonstrated that HF possesses a substantial pro-
tective ability against H2O2-induced mRGC cell death in the progression
of DR.
3.6. HF suppressed H2O2-induced mRGC cell apoptosis
To further conﬁrm the protective action of HF against H2O2-trig-
gered mRGC cell apoptosis, ﬂow cytometric analysis of mRGC cell
double-stained with Annexin V/7-AAD was performed to unveil whe-
ther any early or late apoptotic mRGC cell with diﬀerent interventions
(Fig. 5E). The exposure to 0.236 mM H2O2 alone elicited an signiﬁcant
increasing apoptotic rate (average early and late apoptotic rate: 2.9%
and 18.4%), compared with untreated (1.9% and 1.2%) or pretreated
cells at low (3.1% and 1.9%) or high dose (2.4% and 1.6%) of HF
(Fig. 5F–I). HF pretreatment with either low or high dose for 24 h could
promote the quantity of viable mRGC cells, as well as reduce necrotic
cells in comparison with the H2O2 alone treatment. Therefore, we
postulate that HF acts as a pivotal role in repressing the mRGC cell
apoptosis, especially presenting a considerable inhibitory eﬀect on the
increase of late-apoptotic mRGC.
3.7. HF inhibited Caspase-3 activity and ROS production in H2O2-stressed
mRGC cell
The caspase-dependent cascade activation is identiﬁed as one of the
most characteristic events in the mitochondria-related apoptosis
pathway (Kumar et al., 2017). Caspase-3, a member of cysteine pro-
tease family, is fully activated in the execution of programmed cell
apoptosis (Ghavami et al., 2009). The colorimetric assay of caspase-3
was utilized to determine whether caspase-3 cleavage was in the in-
volvement of H2O2-induced mRGC cell apoptosis. As shown in Fig. 4J,
Fig. 5. HF attenuates H2O2-induced mRGC cell death and apoptosis via downregulation of cleaved Caspase-3 and ROS generation, analyzed by MTT assay and ﬂow cytometer.
(A) mRGC cell viability upon H2O2 treatment for 24 h, H2O2 concentrations are converted to its corresponding log10 equivalents. (B) Stimulation of mRGCs to media alone (Control) or
diﬀerent concentrations (50–800 μg/ml) of HF for 24 h, respectively. Cell viability is expressed as percentages of control. (C) mRGCs cultured with media and H2O2 (0.236 mM) for 24 h
(Model) or co-treated with an increasing amount of HF (13–400 μg/ml) and H2O2 simultaneously for 24 h (HF+ H2O2). (D) Incubation of mRGCs with media or H2O2 (0.236 mM) for 48 h
(Model) or pre-treated with HF (13–400 μg/ml) for 24 h followed by 0.236 mM H2O2 post-treatment for another 24 h (HF+H2O2). (E) Detection of mRGC apoptosis assessed by ﬂow
cytometry using double-immunostaining PE-Annexin V and 7-ADD. mRGCs were untreated (top left), treated with 0.236 mM H2O2 for 48 h (top right) or either pretreatment with low
(bottom left) or high dose (bottom right) of HF for 24 h followed by 0.236 mM H2O2 incubation for another 24 h. (F-K) Average percentage of mRGCs in respective stage, according to the
four quadrants of each contour diagram in Fig. 2(E). (F) viable cell. (G) early apoptotic cell (H) late apoptotic cell (I) necrotic cell. (J, K) Caspase-3 activity and ROS generation of mRGCs
after pretreated with HF for 24 h followed by 0.236 mM H2O2 treatment for 24 h. All data are presented as mean± S.D. based on three independent experiments. HF (LD): HF 25 μg/ml;
HF (HD): HF 50 μg/ml. (*) P<0.05, (**) P<0.01 and (***) P<0.001 versus Model.
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pretreatment with low (OD: 0.074± 0.007) or high dose (OD:
0.068± 0.003) of HF for 24 h was conﬁrmed to signiﬁcantly attenuate
the activation of cleaved caspase-3, compared with untreated (OD:
0.066± 0.003) or H2O2-treated mRGC cell (OD: 0.107±0.005) for
48 h. These outcomes further elucidated that HF had an inhibitory ef-
fect on mRGC cell apoptosis via repressing caspase-3 activity.
An excessive amount of ROS generation is recognized as a con-
vinced hallmark of oxidative stress in the pathogenesis of DR, which
can be initiated by overproduction of H2O2 (Newsholme et al., 2016). It
revealed that H2O2 remarkably enhanced ROS production in mRGCs
compared with untreated cells, whereas signiﬁcant repression of ROS is
elicited under HF pretreatment for 24 h (Fig. 5K). This indicates that HF
could eﬃciently prevent H2O2-induced mRGC apoptosis at least partly
due to its anti-oxidant eﬀect via decrease of ROS production.
3.8. HF alleviated H2O2-triggered endoplasmic reticulum- or mitochondria-
dependent stress in mRGC cell
Accumulating evidence elucidated that chronic exposure of H2O2
could contribute to cell apoptosis in response to endoplasmic reticulum-
or mitochondria-dependent stress (Liu et al., 2017a; Ye et al., 2014). It
is a noticeable strategy to unveil the assumed pro-survival role of HF
against H2O2-induced mRGC apoptosis in DR. We further investigated
the expressions of endogenous endoplasmic reticulum- or mitochon-
dria-dependent protein, such as phospho-p38 MAPK, ATF4 and CHOP
proteins. As shown in Fig. 6A, by comparison to the H2O2-treated cells
for 48 h, phosphor-p38 MAPK, ATF4 and CHOP proteins (Fig. 6B–D)
were signiﬁcantly down-regulated by either low or high dose of HF
pretreatment for 24 h. Concomitantly, high-dose HF administration
remarkably improved the expressions of Bcl-XL and Bcl-2 (Fig. 6E–F)
proteins. These aforementioned ﬁndings suggested that a potential
participation of both endoplasmic reticulum- and mitochondria-dys-
function activated proteins in the reversible progression of H2O2-
induced mRGC cell apoptosis by HF in DR.
3.9. HF restored H2O2-induced loss of postsynaptic protein PSD-95 in
mRGCs
PSD-95, a membrane-associated guanylate kinase, is a critical
postsynaptic scaﬀolding protein that promotes the stabilization of sy-
naptic contacts as well as neural plasticity in RGC cells (Lam et al.,
2016). As compared to untreated or H2O2 alone treated cells. HF pre-
treatment for 24 h could extensively restore the loss of PSD-95 in H2O2-
stressed cells (Fig. 6G), showing a protective function of HF in in-
hibiting the decrease of postsynaptic proteins in response to prolonged
H2O2 exposure to mRGCs.
4. Discussion
Therapeutic strategy designed by searching for safer alternative
medicines equipped with multi-target therapy and minimal side eﬀects
accelerates the development of novel treatments for DR. Besides ex-
ploiting conventional western medicine, herbal formulae taken for di-
versiﬁed medicinal reasons on the basis of clinical eﬃciency are in-
creasingly popular and deemed to encompass advantage of innately safe
to a certain extent (More et al., 2017). Although the neuroprotective
mechanisms of HF on oxidative stress and endoplasmic reticulum- in-
duced retinal degeneration have not been thoroughly elaborated, sev-
eral ﬁndings in which we have addressed are demonstrated in the
present study. Intensive exposure of H2O2 considerably reduced the
survival number of mRGCs, while such pathological change could be
reversed via HF treatment, indicating the neuroprotective property of
HF on DR treatment. Moreover, redundant ROS generation is char-
acterized by the substantial impact on the progression of DR and sub-
sequently caused microvascular disease due to the imbalanced corre-
lation between pro- and anti-oxidants (Fan et al., 2016; Lam et al.,
Fig. 6. HF suppressed H2O2-triggered mRGC cell apoptosis via mediating endoplasmic reticulum- or mitochondria-dependent protein expressions. (A) Expression of phospho-
p38 MAPK, ATF4, Bcl-XL, Bcl-2, CHOP, PSD-95, GAPDH at protein levels in mRGC cells. Cells were treated in the presence of 0.236 mM H2O2 (model) or not (Control) for 48 h.
Otherwise, cells were either pretreated with low (LD) or high dose (HD) of HF for 24 h followed by 0.236 mM H2O2 exposure for another 24 h. (B, C, D, E, F, G) Bar charts show the mean
intensity of each protein quantiﬁed and normalized relative to GAPDH expression. Values are presented as mean±S.D. based on independent experiments in triplicate. HF (LD): HF
25 μg/ml; HF (HD): HF 50 μg/ml. (*) P<0.05, (**) P<0.01 and (***) P<0.001 versus model.
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2016; Li et al., 2015). It is particularly worth mentioning that the H2O2-
induced ROS production is greatly attenuated in HF-treated mRGCs, as
illustrated by the declined intensity of DCFDA ﬂuorescence. Thus, our
data indicated that HF was observed as an neuroprotectant coupled
with the promotion of anti-oxidative activity in the intracellular com-
partment.
Another noteworthy factor is that mitochondrial dysfunction may
account for the main source of ROS production and contribute to DR
progression, but it is no longer considered as a sole etiology.
Accumulated ROS could lead to the activation of endoplasmic reticulum
stress, whereas long-term endoplasmic reticulum stress, containing the
presence of excessive H2O2, could further generate ROS owing to the
stimulation of CHOP-mediated apoptosis accompanied with mitochon-
dria-dependent cell death stimuli (Wang et al., 2016). As shown in the
previous report, CHOP, a pro-apoptotic transcriptional eﬀector of en-
doplasmic reticulum stress-induced apoptosis, is responsible for ele-
vated ROS production and strengthen the feedback of apoptosis re-
sponse due to the up-regulation of Ero-1α expression, regarding as a
thiol oxidase for the inducement of ROS generation (Namba et al.,
2009). Our in vitro results are in agreement with previous reports il-
lustrating that an inverse correlation between the survival mRGCs and
CHOP-associated expressions is unveiled in the induction of over-
expression of ROS. More speciﬁcally, besides the highly expressed
CHOP via H2O2 intervention in mRGCs, the expressions of ATF4,
phosphorylated p38 MAPK and cleaved caspase-3 were simultaneously
enhanced in mRGCs, which were attenuated by HF. ATF4 was regarded
as a critical upstream transcription factor of CHOP. Furthermore, ATF4-
CHOP-mediated induction of unfolded protein response and genes en-
coding protein synthesis was conﬁrmed to promote the RGC death (Han
et al., 2013). Activation of p38 MAPK has generally been detected not
only in the involvement of overloaded intracellular ROS but also
spontaneous caspase-3-mediated cell apoptosis (Jameel et al., 2009).
Caspase-3, an intracellular cysteine protease, performed as a terminal
eﬀector of the mitochondria-dependent apoptotic pathway. As re-
ported, mitochondrial ROS content was elevated in rats exposed to STZ
and caspase-3 was concomitantly increased in RGCs (Yang et al.,
2013b), which results are consistent with our results determined by
caspase-3 colorimetric assay kit. Furthermore, in our present study,
pretreatment of mRGCs with HF has conﬁrmed to concomitantly restore
the expression of Bcl-2 and Bcl-xL, after undergoing H2O2 treatment
which might be potentially contributed to the inhibition of cascaded
pathological mechanisms in DR mice. On account of the amelioration of
apoptosome-mediated caspases-3 cleavage via HF treatment, we might
further speculate that HF could prevent the formation of apoptosome,
constituted with three major components: mitochondria-derived cyto-
chrome C (Cyt-C), Apaf-1 and protease caspase‐9.
RGCs, located in the ganglion cell layer of the retinae, are the output
neurons transmitting information on light to image-forming regions in
the brain through the integration between the dendrite and synaptic
connections. PSD 95, a major postsynaptic scaﬀolding protein, partici-
pated in the synaptic plasticity and protein assembly. According to
literatures, the expression of PSD 95 is declined in the disease of neu-
rodegeneration that is in agreement with our present outcomes both in
vitro and in vivo (Gylys et al., 2004), indicating that pretreatment with
HF results in positive eﬀects on maintaining the level of PSD 95 in
H2O2-induced cell apoptosis as well as the neuroprotection of surviving
population of RGCs with the counter immunostaining of Brn3a and PSD
95 in STZ-treated diabetic mice. Moreover, activation of ATF4, nega-
tively regulates synaptic plastic leading to the repression of synapse
genes and cleaved-caspase-3 has been reported to the contribution of
the early postsynaptic dendrites dysfunction (D'Amelio et al., 2011;
Pasini et al., 2015). Thus, gradual loss of PSD-95 resulted from the H2O2
overexpression in mRGCs or STZ-induced pathological stresses in dia-
betic mice may be ameliorated via HF treatment through inhibiting the
activation of endoplasmic reticulum stress or oxidative stress associated
pathological components involving cleaved-caspase-3, ATF4 and its
downstream substrate CHOP.
Interestingly, in our study, HF elicited ﬂuctuating hypoglycemic
action and not as potent as insulin done in diabetic mice. While insulin-
treated diabetic mice undergone progressive vascular degeneration, as
similar to the untreated DR mice, which is in agreement with previous
reports that intensive insulin therapy contributed to the aggravation of
retinal neovascularization in DR, possibly via up-regulating the ex-
pression of insulin-like growth factor-1 (IGF-1), hypoxia-inducible
factor 1a (HIF-1α) and VEGF (Kaya et al., 2013; Mao et al., 2017).
Genetic suppression of ATF4 activity attenuated diabetic-caused retinal
vascular leakage and neovascularization associated with enriched
avascular ﬁelds (Chen et al., 2012; Zeng et al., 2013). Overexpression of
oxidized and glycated low-density lipoprotein (HOG-LDL) is implicated
in apoptotic pericytes loss by the activation of CHOP-mediated en-
doplasmic reticulum- or oxidative-stress (Fu et al., 2012). Herein, in-
duction of ATF4 and CHOP pathway might promote the increased E/P
ratio in combination with neurovasculopathy in DR mice, which,
however, could be alleviated via HF treatment.
Increasing circumstantial evidence of histological material has re-
vealed that RGCs deemed to be lost in patients and mice with DR (Kern
and Barber, 2008; Yang et al., 2012). Moreover, the massive absence of
RGCs might further correlate with reduction of inner retinal layers in
DR and contribute to vision loss (Shimazawa et al., 2012). Our ﬁndings
were inconsistent with previous reports showing that a cumulative
decrease in the quantity of RGCs combined with elevated expression of
CHOP immunostaining was demonstrated in DR mice, and associated
with the reduction of H&E stained GCL, INL, and IPL, which, however,
was alleviated via HF treatment. Activation of ER stress in the early
stage of DR resulted in adverse eﬀect on RGC population, contributing
to the onset of RGC apoptosis, and was subsequently responsible for
RGC loss in DR mice (van Dijk et al., 2009). In addition, increasing in C/
ERB homologous- or caspase-dependent protein, involving ATF4, CHOP
and caspase-3, were reported to act as a positive role in the neuronal
loss as well as retinal microvascular abnormalities in DR (Kowluru and
Koppolu, 2002; Yang et al., 2013c), which might further give rise to the
changes of pathomorphology and functional disorders in the retinae.
Remarkably, thinning of inner retina, especially in IPL, is speciﬁcally
correlated with gradual loss of neural dendrites and synapses (Barber
et al., 1998), probably concomitant with the decrease of PSD 95 as il-
lustrated in the present study.
5. Conclusion
Taken aforementioned ﬁndings in the study, originating from both
in vitro and in vivo experiments, schematic with hypothetical me-
chanisms of pharmacological actions of HF against DR were outlined in
Fig. 7. It is tempting to ascertain that HF is endowed with multiple
protective functions against diabetes-induced RGC apoptosis coupled
with retinal microvascular and structural degeneration, such as the
destruction of vascular permeability, RGC loss and thinning of inner
retinal layer, by scavenging ROS and simultaneously strengthening the
attenuation of the activation of ATF4/CHOP-mediated endoplasmic
reticulum stress or mitochondria-dependent pro-apoptotic factors, in-
cluding cleaved-caspase-3, and phosphor-p38 MARK, and subsequently
lead to restoration of postsynaptic PSD 95 protein. Meanwhile, the
expressions of anti-apoptotic factors like Bcl-2 and Bcl-xL, involved in
the prevention of DR, were concomitantly enhanced with the purpose
of reinforcing the endogenous defense system. Hereby, HF treatment
was convinced to be a novel therapeutic approach not only of alle-
viating RGC apoptosis but of postponing the onset and progression of
DR.
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